Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
M K KuhlmannH Köhler

Abstract

Cisplatin preferentially accumulates in cells of the S3 segment of the renal proximal tubule and is toxified intracellularly by hydration. The earliest manifestation of toxicity is inhibition of protein synthesis. GSH depletion is another important mechanism causing CP toxicity. Intracellular binding to SH groups leads to GSH depletion, resulting in lipid peroxidation and eventually mitochondrial damage. New measures to prevent GSH depletion and scavenge intracellular free oxygen radicals have been tried in clinical studies. Promising results indicate that cisplatin nephrotoxicity can be further reduced in the future.

Citations

May 20, 2005·Archives of Toxicology·Enes Murat AtasoyuE Gökhan Kandemir
Jul 21, 2006·Cancer Chemotherapy and Pharmacology·Sherif Y SaadTawfeeg A Najjar
Aug 29, 2009·Cancer Chemotherapy and Pharmacology·Frederick H HausheerAulma R Parker
May 5, 2010·Cancer Chemotherapy and Pharmacology·F H HausheerH Kochat
Oct 31, 2007·Apoptosis : an International Journal on Programmed Cell Death·H ServaisM-P Mingeot-Leclercq
Jul 1, 2011·Journal of Natural Medicines·Yamini B TripathiShashi Pandey Rai
Jun 18, 2002·European Journal of Pharmacology·Satyanarayan G BhatVickram Ramkumar
Oct 15, 2003·Free Radical Biology & Medicine·Yuki ShinoRyozo Oishi
Oct 3, 1999·Kidney International·A H Lau
Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T BrodowiczC Manegold
Jul 14, 2010·Southern Medical Journal·Tamim HamdiAshok Patel
Sep 7, 2004·Chemotherapy·Mohamed M Sayed-AhmedAbdel-Moneim M Osman
Dec 6, 2005·Urologia Internationalis·Meltem Ozlen DillioglugilOzdal Dillioglugil
Feb 11, 2003·Biological & Pharmaceutical Bulletin·Kohji TakaraTeruyoshi Yokoyama
Mar 3, 2012·Archives of Toxicology·Neife Aparecida Guinaim dos SantosAntonio Cardozo dos Santos
Mar 19, 2014·European Journal of Pharmacology·Mai M HelmyMahmoud M Mohy El-Din
Apr 27, 2010·Inflammation·Alan Arrieira AzambujaJarbas Rodrigues de Oliveira
Aug 29, 2014·BioMed Research International·Abdullah Ozkok, Charles L Edelstein
Feb 11, 2015·Chemico-biological Interactions·Marcia C da Silva FariaAntonio Cardozo Dos Santos
May 15, 2007·Renal Failure·Secil AydinozRifki Evrenkaya
Feb 24, 2011·Journal of Pharmaceutical Sciences·F H HausheerA R Parker
Aug 19, 2007·The American Journal of the Medical Sciences·Xin YaoKenneth Nugent
Mar 8, 2011·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Yuko TogashiYohei Miyamoto
Jun 1, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Santosh Nagwani, Yamini B Tripathi
Jan 30, 2010·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Martins EkorEbenezer O Farombi
Aug 4, 2009·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Sara A KhanAhad N K Yusufi
Apr 23, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Richard David WainfordGabrielle M Hawksworth
Dec 10, 2008·Archives of Medical Research·Bernardo OchoaLuis A Herrera
Feb 17, 2007·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Yao-Ching HungPei-San Se
Nov 5, 2015·Canadian Journal of Physiology and Pharmacology·Hayam AteyyaManar A Nader

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.